06/09/2025 3:16 PM | Celldex Therapeutics (Issuer) PEPIN RONALD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2025 3:17 PM | Celldex Therapeutics (Issuer) Martin Samuel Bates (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2025 3:18 PM | Celldex Therapeutics (Issuer) Jimenez Freddy A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2025 3:21 PM | Celldex Therapeutics (Issuer) Heath-Chiozzi Margo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2025 3:22 PM | Celldex Therapeutics (Issuer) Crowley Elizabeth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2025 3:22 PM | Cavanaugh Sarah (Reporting) Celldex Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2025 7:05 AM | Celldex Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2025 7:10 AM | Celldex Therapeutics (Issuer) Torres Denice (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/15/2025 10:48 AM | Celldex Therapeutics (Subject) Kynam Capital Management, LP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025 9:44 AM | Celldex Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
04/21/2025 7:01 AM | Celldex Therapeutics (Filer)
| Form DEF 14A | |
04/10/2025 3:05 PM | Celldex Therapeutics (Subject) COMMODORE CAPITAL LP (Filed by)
| Form SCHEDULE 13G | |
02/27/2025 3:01 PM | Celldex Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 4:16 PM | Celldex Therapeutics (Subject) Kynam Capital Management, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 8:44 AM | Celldex Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/12/2025 8:28 AM | Celldex Therapeutics (Subject) FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
11/14/2024 6:47 PM | Celldex Therapeutics (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024 11:18 AM | Celldex Therapeutics (Subject) EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024 5:12 AM | Celldex Therapeutics (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/13/2024 5:00 PM | Celldex Therapeutics (Subject) Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
11/12/2024 8:55 AM | Celldex Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
11/08/2024 9:52 AM | Celldex Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024 3:06 PM | Celldex Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |